[BGLC] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
31-May-2024
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 56.05%
YoY- -505.88%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 2,273 2,554 2,567 2,377 2,840 2,575 2,485 -5.75%
PBT 253 -2,532 -275 -53 -127 -67 -140 -
Tax -55 76 -16 16 30 10 -2 805.59%
NP 307 -2,608 -259 -69 -157 -77 -139 -
Tax Rate 21.74% - - - - - - -
Total Cost 1,966 5,162 2,826 2,446 2,997 2,652 2,624 -17.46%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 13.52 -102.13 -10.10 -2.91 -5.53 -3.01 -5.58 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS 0.02 -0.16 -0.02 -0.00 -0.01 -0.01 -0.01 -
EPS Diluted 0.02 -0.16 -0.02 -0.00 -0.01 -0.01 -0.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.